6G mobile networks will need up to three times today's spectrum to meet surging data demands, new GSMA report shows.

6G mobile networks will need up to three times today's spectrum to meet surging data demands, new GSMA report shows.

Near-term government decisions to avoid future spectrum 'bottlenecks' are needed to benefit billions of consumers and businesses in a 6G world. LONDON, Nov. 20, 2025 /PRNewswire/ -- Next-generation 6G networks will require up to three times more...

New Research from UpGuard Reveals 68% of Security Leaders Admit to Unauthorized AI Usage

New Research from UpGuard Reveals 68% of Security Leaders Admit to Unauthorized AI Usage

The study also shows 8 out of 10 employees use unauthorized AI, eroding corporate trust MOUNTAIN VIEW, Calif., Nov. 10, 2025 /PRNewswire/ -- UpGuard, a leader in cybersecurity and risk management, today released its new "State of Shadow AI" report....

Warmy's Journey: From the Andes to Shanghai

Warmy's Journey: From the Andes to Shanghai

SHANGHAI, Nov. 6, 2025 /PRNewswire/ -- A news report from english.shanghai.gov.cn Once unnoticed in the Peruvian highlands, an alpaca plush named Warmy found new life in Shanghai. From a tiny booth at the China International Import Expo to global...

Xinhua Silk Road: How can I repay you, SJTU

Xinhua Silk Road: How can I repay you, SJTU

Beijing, Oct. 28, 2025 /PRNewswire/ -- Niladri, an international student from Bangladesh at Shanghai Jiao Tong University (SJTU), drags his suitcase and wanders around the SJTU campus for the last time -- soon, he will head to Singapore to embark on...

Innovent's Mazdutide Shows Superiority in Glycemic Control with Weight Loss over Semaglutide in a Head-to-head Phase 3 Clinical Trial DREAMS-3

Innovent's Mazdutide Shows Superiority in Glycemic Control with Weight Loss over Semaglutide in a Head-to-head Phase 3 Clinical Trial DREAMS-3

The proportion of participants achieving HbA1c < 7.0% and a ≥10% reduction in body weight from baseline was 48.0% in the mazdutide group and 21.0% in the semaglutide group DREAMS-3 is the world's first Phase 3 clinical trial of a GCG/GLP-1 dual...

Global Demand for Business Education Grows Amid Economic and Geopolitical Uncertainty

Global Demand for Business Education Grows Amid Economic and Geopolitical Uncertainty

GMAC's latest Application Trends Survey shows student mobility is shifting away from English- speaking countries while schools accelerate AI, sustainability integration. RESTON, Va., Oct. 21, 2025 /PRNewswire/ -- Graduate management education (GME)...

Three years on, Zhongshan shows visible progress in "High-Quality Development Project"

Three years on, Zhongshan shows visible progress in "High-Quality Development Project"

ZHONGSHAN, China, June 5, 2025 /PRNewswire/ -- Since the launch of the "High-Quality Development Project for Counties, Towns and Villages," Zhongshan City has implemented the "1310" development strategy put forward by CPC Guangdong Provincial...

Neuronata-R® Stem Cell Therapy Shows Promise in ALS Phase 3 Subgroup Analysis, Moves Toward FDA Accelerated Approval

Neuronata-R® Stem Cell Therapy Shows Promise in ALS Phase 3 Subgroup Analysis, Moves Toward FDA Accelerated Approval

Meaningful efficacy observed in slow-progressor subgroup; NfL biomarker improvements support potential for accelerated regulatory pathway SEOUL, South Korea, May 29, 2025 /PRNewswire/ -- Neuronata-R®, an autologous bone marrow-derived mesenchymal...

Blackbaud Institute 2025 Status of ANZ Fundraising Benchmark Report Shows Growing Recognition of AI and its Impact on Fundraising Success

Blackbaud Institute 2025 Status of ANZ Fundraising Benchmark Report Shows Growing Recognition of AI and its Impact on Fundraising Success

Tech-Savvy Organisations See Substantial Benefits with AI Use SYDNEY, May 28, 2025 /PRNewswire/ -- The Blackbaud Institute, a research lab at Blackbaud (NASDAQ: BLKB), the leading provider of software for powering social impact, today released a new...

SeekInCare: New Multi-Omics Blood Test Shows Promise for Early Cancer Detection Across Multiple Cancer Types

SeekInCare: New Multi-Omics Blood Test Shows Promise for Early Cancer Detection Across Multiple Cancer Types

SAN DIEGO, May 26, 2025 /PRNewswire/ -- A groundbreaking study published in the Journal of Molecular Diagnostics reports the successful clinical validation of SeekInCare®, a novel, non-invasive multi-omics blood test designed for the early detection...

  • 1
  • 2
  • menu
    menu